Bioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers
{{output}}
A bioequivalence study of 2 zolmitriptan (CAS 139264-17-8) orodispersible tablet formulations was carried out in 26 healthy volunteers according to an open label, randomized, 2-period, 2-sequence, crossover, single dose and fasting conditions design. The test ... ...
